Orchestra BioMed Holdings, Inc.
OBIO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001814114
In the last 90 days, Orchestra BioMed Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $58.6K in total
- 2
- Insider sellsLast 90 days, $199.5K in total
- 3
- 13F holdersQ2 2026, +12 vs. previous quarter
- 77
- 13F valueReported value at the end of Q2 2026
- $119.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OBIO, Q2 2026
No superinvestor reported holding OBIO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Orchestra BioMed Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)8:15 AM ET | Sep 3 | 5 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +10.0K | $4.79 | +$47.9K | +0.9%1.07M after | |
| Sep 2, 2026 (view filing)4:15 PM ET | Sep 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −15.0K | $4.94 | −$74.1K | −1.3%1.13M after | 10b5-1 |
| Aug 28, 2026 (view filing)4:15 PM ET | Aug 26 | 2 days | Sherman DarrenSee Remarks | PPurchase | +2.00K | $5.33 | +$10.7K | New position2.00K after | |
| Aug 4, 2026 (view filing)4:49 PM ET | Aug 3 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $4.09 | −$61.4K | −1.3%1.15M after | 10b5-1 |
| Jul 2, 2026 (view filing)4:15 PM ET | Jul 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $4.27 | −$64.0K | −1.3%1.17M after | 10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $3.83 | +$19.1K | +0.5%1.06M after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $3.87 | −$58.0K | −1.3%1.18M after | 10b5-1 |
| May 20, 2026 (view filing) | May 18 | 2 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +665 | $3.75 | +$2.49K | +0.6%118.1K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +8.97K | $3.90 | +$35.0K | +8.3%117.5K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $3.77 | +$18.9K | +0.5%1.06M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Orchestra BioMed Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 9,556,063 | $41.2M | 0.35% | +1,250,000+15.0% | Added |
| Perceptive Advisors LLC | 5,037,906 | $21.7M | 0.34% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,510,387 | $10.8M | 0.00% | +1,874,673+294.9% | Added |
| Vanguard Capital Management LLC | 2,022,916 | $8.73M | 0.00% | −181,403−8.2% | Reduced |
| Geode Capital Management, LLC | 1,007,908 | $4.35M | 0.00% | +522,416+107.6% | Added |
| Alyeska Investment Group, L.P. | 1,000,000 | $4.32M | 0.01% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 896,701 | $3.87M | 2.02% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 642,154 | $2.77M | 0.00% | +642,154 | New |
| State Street Corp | 516,050 | $2.23M | 0.00% | +346,640+204.6% | Added |
| Rice Hall James & Associates, LLC | 424,000 | $1.83M | 0.09% | +404,999+2,131.5% | Added |